Random Screening for Dominant-Negative Mutants of the Cytomegalovirus Nuclear Egress Protein M50

ABSTRACT Inactivation of gene products by dominant-negative (DN) mutants is a powerful tool to assign functions to proteins. Here, we present a two-step procedure to establish a random screen for DN alleles, using the essential murine cytomegalovirus gene M50 as an example. First, loss-of-function mutants from a linker-scanning library were tested for inhibition of virus reconstitution with the help of FLP-mediated ectopic insertion of the mutants into the viral genome. Second, DN candidates were confirmed by conditional expression of the inhibitory proteins in the virus context. This allowed the quantification of the inhibitory effect, the identification of the morphogenesis block, and the construction of DN mutants with improved activity. Based on these observations a DN mutant of the homologous gene (UL50) in human cytomegalovirus was predicted and constructed. Our data suggest that a proline-rich sequence motif in the variable region of M50/UL50 represents a new functional site which is essential for nuclear egress of cytomegalovirus capsids.

[1]  L. Frati,et al.  Characterization and Intracellular Localization of the Epstein-Barr Virus Protein BFLF2: Interactions with BFRF1 and with the Nuclear Lamina , 2005, Journal of Virology.

[2]  T. Shenk,et al.  Functional map of human cytomegalovirus AD169 defined by global mutational analysis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Walther,et al.  Freeze substitution of high‐pressure frozen samples: the visibility of biological membranes is improved when the substitution medium contains water , 2002, Journal of microscopy.

[4]  V. Štolc,et al.  Functional profiling of a human cytomegalovirus genome , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  F. Yao,et al.  A novel tetracycline-inducible viral replication switch. , 1999, Human gene therapy.

[6]  K. Nagashima,et al.  Late viral interference induced by transdominant Gag of an endogenous retrovirus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Wands,et al.  Characterization of hepatitis B virus core mutants that inhibit viral replication. , 1994, Virology.

[8]  U. Koszinowski,et al.  Common and Specific Properties of Herpesvirus UL34/UL31 Protein Family Members Revealed by Protein ComplementationAssay , 2006, Journal of Virology.

[9]  U. Koszinowski,et al.  Comprehensive Mutational Analysis of a Herpesvirus Gene in the Viral Genome Context Reveals a Region Essential for Virus Replication , 2004, Journal of Virology.

[10]  S. Jonjić,et al.  Gain of Virulence Caused by Loss of a Gene in Murine Cytomegalovirus , 2004, Journal of Virology.

[11]  Brent J. Ryckman,et al.  Ultrastructural Localization of the Herpes Simplex Virus Type 1 UL31, UL34, and US3 Proteins Suggests Specific Roles in Primary Envelopment and Egress of Nucleocapsids , 2002, Journal of Virology.

[12]  I. Herskowitz.  Functional inactivation of genes by dominant negative mutations , 1987, Nature.

[13]  P. Elias,et al.  Inhibition of herpes simplex virus type 1 DNA replication by mutant forms of the origin-binding protein. , 1993, Virology.

[14]  U. Koszinowski,et al.  Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis , 1999, Nature Biotechnology.

[15]  W. Hammerschmidt,et al.  Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  U. Koszinowski,et al.  Functional Domains of Murine Cytomegalovirus Nuclear Egress Protein M53/p38 , 2006, Journal of Virology.

[17]  Brent J. Ryckman,et al.  UL31 and UL34 Proteins of Herpes Simplex Virus Type 1 Form a Complex That Accumulates at the Nuclear Rim and Is Required for Envelopment of Nucleocapsids , 2001, Journal of Virology.

[18]  W. Sundquist,et al.  The Protein Network of HIV Budding , 2003, Cell.

[19]  J. Heesemann,et al.  A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. , 2001, Science.

[20]  G. Nolan,et al.  Gene therapy progress and prospects: Novel gene therapy approaches for AIDS , 2005, Gene Therapy.

[21]  U. Koszinowski,et al.  Role of Murine Cytomegalovirus US22 Gene Family Members in Replication in Macrophages , 2003, Journal of Virology.

[22]  J. Wands,et al.  Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents , 1995, Hepatology.

[23]  S. Goff,et al.  Mutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection , 1984, Journal of virology.

[24]  S. Jonjić,et al.  Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs , 1985, Journal of virology.

[25]  J. Haas,et al.  Cytomegalovirus Recruitment of Cellular Kinases to Dissolve the Nuclear Lamina , 2002, Science.

[26]  U. Koszinowski,et al.  Conditional Cytomegalovirus Replication In Vitro and In Vivo , 2005, Journal of Virology.

[27]  E. Raleigh,et al.  A simple in vitro Tn7-based transposition system with low target site selectivity for genome and gene analysis. , 2000, Nucleic acids research.

[28]  B. Berger,et al.  Herpesviral Protein Networks and Their Interaction with the Human Proteome , 2006, Science.

[29]  L. Frati,et al.  BFRF1 of Epstein-Barr Virus Is Essential for Efficient Primary Viral Envelopment and Egress , 2005, Journal of Virology.

[30]  A. Adachi,et al.  Inhibition of HIV/SIV Replication by Dominant Negative Gag Mutants , 2004, Virus Genes.

[31]  K. Kirkegaard,et al.  Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses , 2005, Nature Genetics.

[32]  U. Koszinowski,et al.  Herpesvirus genetics has come of age. , 2002, Trends in microbiology.

[33]  B. Roizman,et al.  The essential protein encoded by the UL31 gene of herpes simplex virus 1 depends for its stability on the presence of UL34 protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Imhof,et al.  Comparative study and identification of potent eukaryotic transcriptional repressors in gene switch systems. , 2002, Journal of biotechnology.

[35]  S. McKnight,et al.  Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus , 1988, Nature.

[36]  W. Wackernagel,et al.  Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. , 1995, Gene.

[37]  Fulvio Mavilio,et al.  Gene therapy , 1993, Nature.

[38]  L. Hutt-Fletcher,et al.  The Epstein-Barr virus BFRF1 and BFLF2 proteins interact and coexpression alters their cellular localization. , 2004, Virology.

[39]  D. Baltimore.  Gene therapy. Intracellular immunization. , 1988, Nature.

[40]  N. Cheshenko,et al.  Focal Adhesion Kinase Plays a Pivotal Role in Herpes Simplex Virus Entry* , 2005, Journal of Biological Chemistry.

[41]  U. Koszinowski,et al.  Role of human cytomegalovirus UL131A in cell type-specific virus entry and release. , 2006, The Journal of general virology.